Archives epizyme

by in
Entry Author Date Location
Xconomy Boston’s Top 10 Stories from Q3 2013: Editor’s Picks 09/30/13 Boston
Which VCs Are Poised to Profit From the Biotech IPO Boom? 09/09/13 National
Biotech and Fantasy Football Picks for Fall 2013 09/03/13 National
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
Who Should Biotech Pros Follow on Twitter? An Update for 2013 08/19/13 National
East Coast Life Sciences Roundup: Epizyme, Rodin, Ophthotech, & More 08/16/13 Boston
Epizyme Execs Share the Secret to a Successful IPO: PowerBars 08/15/13 Boston
Atlas Startup, Rodin, Hopes to Rewire Neurons to Improve Memory 08/12/13 Boston
East Coast Life Sciences Roundup: KiiLN, Celgene, Acceleron, & More 08/09/13 New York
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
U.S. Venture Activity Remains Steady as IPOs Rise in Second Quarter 07/16/13 National
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
East Coast Life Sciences Roundup: Verdine, Vedanta, Alnylam, & More 07/05/13 Boston
Xconomy Boston’s Top 20 Stories of Q2 2013: Editor’s Picks 07/01/13 Boston
The Biotech IPO Scorecard: Who’s Up, Who’s Down in 2013 06/03/13 National
Epizyme Soars 50 Percent in IPO Debut 05/31/13 Boston
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
Epizyme Prices IPO at $15 Per Share, Begins Trading Friday 05/30/13 Boston
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
East Coast Life Sciences Roundup: Thermo, Alkermes, Acorda, Epizyme 04/19/13 Boston
Presage Snags $13M from Celgene to Pick Winning Cancer Drug Combos 03/05/13 Seattle
Brook Byers of Kleiner Perkins on Sticking With Healthcare 01/16/13 San Francisco
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
Gladstone, Sage Bionetworks Top ‘Best Places to Work’ List 08/01/12 National
Genzyme, Epizyme, & Rib-X Among the Week’s Life Sciences Newsmakers 04/27/12 Boston
Epizyme Gets $90M in Epigenetics Partnership with Celgene 04/26/12 Boston
Join Us for a Tweetchat Monday on Biotech Startups 12/02/11 National
Page 2 of 4 « previous page · next page »